A global strategy for tuberculosis research and innovation

Nebiat Gebreselassie, Tereza Kasaeva, Matteo Zignol

Source: Eur Respir J, 56 (5) 2003539; 10.1183/13993003.03539-2020
Journal Issue: November
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Nebiat Gebreselassie, Tereza Kasaeva, Matteo Zignol. A global strategy for tuberculosis research and innovation. Eur Respir J, 56 (5) 2003539; 10.1183/13993003.03539-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis
Source: Eur Respir Monogr 2018; 82: 414-429
Year: 2018

The effectiveness of the national program tuberculosis control in Ukraine and the future strategy
Source: Eur Respir J 2006; 28: Suppl. 50, 130s
Year: 2006

Using a rapid prioritisation process to identify health research priorities in LMICs
Source: International Congress 2018 – Primary care management of COPD
Year: 2018

Scaling-up global implementation of LTBI management: a paradigm shift needed
Source: International Congress 2016 – ERS and tuberculosis
Year: 2016

New experiences from global use of new tools in TB management and control
Source: Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management
Year: 2013

TB "cross-border" - a new challenge in tuberculosis management
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020

The impact of digital health technologies on tuberculosis treatment: a systematic review
Source: Eur Respir J, 51 (1) 1701596; 10.1183/13993003.01596-2017
Year: 2018

Translating scientific discoveries during pandemics: ensuring equity for people affected by COVID-19 and tuberculosis
Source: ERJ Open Res, 6 (4) 00562-2020; 10.1183/23120541.00562-2020
Year: 2020

Tuberculosis research questions identified through the WHO policy guideline development process
Source: Eur Respir J, 53 (3) 1802407; 10.1183/13993003.02407-2018
Year: 2019

Crowdfunding for respiratory research: a new frontier for patient and public engagement?
Source: Eur Respir J, 50 (4) 1701333; 10.1183/13993003.01333-2017
Year: 2017

A cost optimization approach to occupational health screening for tuberculosis
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011

Childhood tuberculosis: progress requires an advocacy strategy now
Source: Eur Respir J 2012; 40: 294-297
Year: 2012

Tuberculosis prevention must integrate technological and basic care innovation
Source: Eur Respir J 2016; 48: 1531-1532
Year: 2016

The exposome concept: a challenge and a potential driver for environmental health research
Source: Eur Respir Rev 2016; 25: 124-129
Year: 2016

Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018

Advancing global programmatic management of latent tuberculosis infection for at risk populations
Source: Eur Respir J 2016; 47:1327-1330
Year: 2016

How to optimise patient and public involvement in your research: Doing science
Source: Breathe 2015; 11:223-227
Year: 2015